UCB launches Eu2bn refi facility

Belgian biopharma group UCB has launched a Eu2bn loan to refinance part of the debt it took on to buy German rival Schwarz Pharma in 2006.

  • 26 Nov 2009

The facility is split into a Eu500m 364 day term loan and a Eu1.5bn three year revolver with an optional one year extension. The deal is being co-ordinated by BNP Paribas Fortis, Commerzbank and Mizuho.

The loan will partly refinance a Eu4bn acquisition facility taken out by UCB ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 7,026 25 11.95
2 Citi 6,449 21 10.96
3 BNP Paribas 5,093 18 8.66
4 Barclays 4,040 11 6.87
5 Lloyds Bank 3,615 14 6.15

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 12,796.80 35 13.50%
2 Wells Fargo Securities 8,855.62 27 9.34%
3 Bank of America Merrill Lynch 8,771.28 25 9.25%
4 JPMorgan 7,423.52 25 7.83%
5 RBC Capital Markets 4,569.28 13 4.82%